The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2020

Volume 16 Number 11

An EAPCI consensus document on patient-oriented management of myocardial revascularisation failure; the retrograde vs antegrade approach from the PROGRESS-CTO Registry; the PIONEER trial studying the BuMA Supreme SES. A mini focus on BRS, with: a sub-analysis of the AIDA trial studying BRS and the impact of the complexity of CAD stratified by the SYNTAX score; magnesium-based BRS in the MAGSTEMI trial; BRS implantation as a putative way to lower the incidence of neoatherosclerosis; BRS design and arterial haemodynamics; five-year clinical outcomes from the ABSORB II trial. Effectiveness of a new generation of LAA closure occluders; embolic protection devices for carotid stenting, and more…

Highlights from this issue

The MAGSTEMI-OCT study
The MAGSTEMI-OCT study
Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, Garcia del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabaté M
December 4, 2020
DOI: 10.4244/EIJ-D-20-00198

Coronary interventions

Expert review
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI
Stefanini G, Alfonso F, Barbato E, Byrne R, Capodanno D, Colleran R, Escaned J, Giacoppo D, Kunadian V, Lansky A, Mehilli J, Neumann F, Regazzoli D, Sanz-Sanchez J, Wijns W, Baumbach A
December 4, 2020 | 10.4244/EIJ-D-20-00487
Editorial comment
Repeat revascularisation: “An ounce of prevention is worth a pound of cure”
Levine G, Denktas A
December 4, 2020 | 10.4244/EIJV16I11A160
Clinical research
Technical and procedural outcomes of the retrograde approach to chronic total occlusion interventions
Tajti P, Xenogiannis I, Gargoulas F, Karmpaliotis D, Alaswad K, Jaffer F, Patel M, Burke M, Garcia S, Krestyaninov O, Koutouzis M, Jaber W, Brilakis E
December 4, 2020 | 10.4244/EIJ-D-19-00441
Editorial comment
The retrograde approach for recanalisation of chronic total occlusions – a risk worth taking?
Werner G
December 4, 2020 | 10.4244/EIJV16I11A161
Short report
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial
Chang C, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys P
December 4, 2020 | 10.4244/EIJ-D-19-00566

Coronary interventions - Mini focus on bioresorbable scaffolds

Clinical research
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R, Tijssen R, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Tijssen J, Piek J, de Winter R, Henriques J, Wykrzykowska J
December 4, 2020 | 10.4244/EIJ-D-18-00884
Clinical research
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, Garcia del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabaté M
December 4, 2020 | 10.4244/EIJ-D-20-00198
Editorial comment
Magnesium-based bioresorbable scaffolds in STEMI. The quest for the optimal bioresorption balance
Gonzalo N, McInerney A
December 4, 2020 | 10.4244/EIJV16I11A162
Preclinical research
Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents
Nicol P, Bulin A, Castellanos M, Stöger M, Obermeier S, Lewerich J, Lenz T, Hoppmann P, Baumgartner C, Fischer J, Steiger K, Haude M, Joner M
December 4, 2020 | 10.4244/EIJ-D-19-00747
Preclinical research
Impact of bioresorbable scaffold design characteristics on local haemodynamic forces: an ex vivo assessment with computational fluid dynamics simulations
Tarrahi I, Colombo M, Hartman E, Tovar Forero M, Torii R, Chiastra C, Daemen J, Gijsen F
December 4, 2020 | 10.4244/EIJ-D-19-00657
Short report
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iniguez-Romo A, Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke